Crescent Biopharma (CBIO) Cash from Financing Activities (2013 - 2026)
Crescent Biopharma (CBIO) reported Cash from Financing Activities of -$6.9 million for Q1 2026, down 367.36% year-over-year from $2.6 million in Q1 2025, and down 103.88% on a QoQ basis from $178.9 million in Q4 2025.
Crescent Biopharma (CBIO) has 13 years of Cash from Financing Activities data on file, last reported at -$6.9 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 367.36% year-over-year to -$6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $317.5 million (up 702.85% YoY) and the FY2025 annual result came in at $323.0 million, up 5983301.26% from the prior year.
- Cash from Financing Activities eased to -$6.9 million in Q1 2026 per CBIO's latest filing, from $178.9 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $178.9 million in Q4 2025 and bottomed at -$6.9 million in Q1 2026.
- The 4-year median for Cash from Financing Activities is $12506.0 (2023), against an average of $32.2 million.
- Peak annual rise in Cash from Financing Activities reached 29372700.0% in 2025, while the deepest fall reached 30438.91% in 2025.
- Tracing CBIO's Cash from Financing Activities over 4 years: stood at $999.0 in 2023, then soared by 4107507.61% to $41.0 million in 2024, then soared by 335.87% to $178.9 million in 2025, then tumbled by 103.88% to -$6.9 million in 2026.
- Per Business Quant, the three latest CBIO Cash from Financing Activities figures stand at -$6.9 million (Q1 2026), $178.9 million (Q4 2025), and -$1.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | -6.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.95 Mn |
| Mar 31, 2026 | -6.95 Mn |
| Dec 31, 2025 | 178.86 Mn |
| Dec 31, 2025 | 178.86 Mn |
| Sep 30, 2025 | -1.25 Mn |
| Sep 30, 2025 | -1.25 Mn |
| Jun 30, 2025 | 146.86 Mn |
| Jun 30, 2025 | 146.86 Mn |
| Mar 31, 2025 | -1.49 Mn |
| Mar 31, 2025 | -1.49 Mn |
| Dec 31, 2024 | 41.04 Mn |
| Dec 31, 2024 | 41.04 Mn |
| Jun 30, 2024 | 500.00 |
| Jun 30, 2024 | 500.00 |
| Mar 31, 2024 | 4,898.00 |
| Mar 31, 2024 | 4,898.00 |
| Dec 31, 2023 | 999.00 |
| Dec 31, 2023 | 999.00 |
| Sep 30, 2023 | 61,616.00 |
| Sep 30, 2023 | 61,616.00 |
| Jun 30, 2023 | 20,114.00 |
| Jun 30, 2023 | 20,114.00 |
| Mar 31, 2023 | 28.74 Mn |
| Mar 31, 2023 | 28.74 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 20,790.00 |
| Sep 30, 2021 | 20,790.00 |
| Mar 31, 2021 | 9.56 Mn |
| Mar 31, 2021 | 9.56 Mn |
| Dec 31, 2020 | 3.89 Mn |
| Dec 31, 2020 | 3.89 Mn |
| Sep 30, 2020 | 4.55 Mn |
| Sep 30, 2020 | 4.55 Mn |
| Jun 30, 2020 | 9.58 Mn |
| Jun 30, 2020 | 9.58 Mn |
| Mar 31, 2020 | 129,972.00 |
| Mar 31, 2020 | 129,972.00 |
| Dec 31, 2019 | 119,822.00 |
| Dec 31, 2019 | 119,822.00 |
| Sep 30, 2019 | 186,770.00 |
| Sep 30, 2019 | 186,770.00 |
| Jun 30, 2019 | 75,767.00 |
| Jun 30, 2019 | 75,767.00 |
| Mar 31, 2019 | 30,554.00 |
| Mar 31, 2019 | 30,554.00 |
| Dec 31, 2018 | 125,965.00 |
| Dec 31, 2018 | 125,965.00 |
| Sep 30, 2018 | 504,774.00 |
| Sep 30, 2018 | 504,774.00 |
| Jun 30, 2018 | -113,923.00 |
| Jun 30, 2018 | -113,923.00 |
| Mar 31, 2018 | 128.93 Mn |
| Mar 31, 2018 | 128.93 Mn |
| Dec 31, 2017 | 19.46 Mn |
| Dec 31, 2017 | 19.46 Mn |
| Sep 30, 2017 | -12,829.00 |
| Sep 30, 2017 | -12,829.00 |
| Jun 30, 2017 | 90.83 Mn |
| Jun 30, 2017 | 90.83 Mn |
| Mar 31, 2017 | 3.67 Mn |
| Mar 31, 2017 | 3.67 Mn |
| Dec 31, 2016 | 1.15 Mn |
| Dec 31, 2016 | 1.15 Mn |
| Sep 30, 2016 | -105,252.00 |
| Sep 30, 2016 | -105,252.00 |
| Jun 30, 2016 | 21.35 Mn |
| Jun 30, 2016 | 21.35 Mn |
| Mar 31, 2016 | 1.27 Mn |
| Mar 31, 2016 | 1.27 Mn |
| Dec 31, 2015 | 3,424.00 |
| Dec 31, 2015 | 3,424.00 |
| Sep 30, 2015 | 20,160.00 |
| Sep 30, 2015 | 20,160.00 |
| Jun 30, 2015 | 15,160.00 |
| Jun 30, 2015 | 15,160.00 |
| Mar 31, 2015 | 75,377.00 |
| Mar 31, 2015 | 75,377.00 |
| Dec 31, 2014 | 6,164.00 |
| Dec 31, 2014 | 6,164.00 |
| Sep 30, 2014 | 424.00 |
| Sep 30, 2014 | 424.00 |
| Jun 30, 2014 | 119,529.00 |
| Jun 30, 2014 | 119,529.00 |
| Mar 31, 2014 | 57.26 Mn |
| Mar 31, 2014 | 57.26 Mn |
| Dec 31, 2013 | 199,073.00 |
| Dec 31, 2013 | 199,073.00 |
| Sep 30, 2013 | 340,109.00 |
| Sep 30, 2013 | 340,109.00 |